Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eagle Strategies LLC is a U.S.-based wealth management organization that offers comprehensive financial planning services through its network of over 1,500 advisors. It operates as a wholly owned subsidiary of New York Life—a Fortune 100 insurance company—and specializes in investment advisory and asset protection solutions for individuals and families. There is no evidence that Eagle Strategies has any involvement with biotechnology, pharmaceuticals, contract research/manufacturing organizations (CRO/CMO), or healthcare product development of any kind.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eagle Strategies.